Pharma Stocks
-
Israel “Izzy” Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn’t?
You don’t become one of the world’s wealthiest hedge fund managers by making ill-advised investing decisions. And make no mistake…
Read More » -
Pharma is the new tech; sector to remain a top bet despite potential US tariffs, says N Jayakumar
Pharmaceutical stocks remain one of the top investment bets despite concerns over potential US tariffs, according to N Jayakumar, Group…
Read More » -
Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative
In July 2026, Merck announced an early, multi-pronged access plan for its investigational once-monthly HIV PrEP pill alimatravir (MK-8527), including…
Read More » -
AbbVie (ABBV) Could Be 3% Undervalued Following Epcoritamab Trial Setback
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors…
Read More » -
Axsome Therapeutics (AXSM) Wins FDA NDA Acceptance, Is The Stock Fully Valued?
Why Axsome Therapeutics Stock Is Back in Focus After the Latest FDA Milestone Axsome Therapeutics (AXSM) is drawing fresh attention…
Read More » -
Amneal Pharmaceuticals (AMRX) Stock May Be Fully Priced Following Its 4.7x Run
Amneal Pharmaceuticals has turned in a very strong share price run over the last few years, yet its valuation checks…
Read More » -
How EMA’s Positive CHMP Opinion on Ubeslo and Evlarco at NewAmsterdam Pharma (NAMS) Has Changed Its Investment Story
NewAmsterdam Pharma Company N.V. and Menarini Group recently reported that the EMA’s CHMP issued a positive opinion recommending EU-wide marketing…
Read More » -
CJMB Stock Soars On Alabama State Pharma Partnership
Callan JMB Inc. stocks have been trading up by 11.89 percent following highly positive sentiment from the latest news coverage.…
Read More » -
3 U.S. Pharma Stocks Worth Watching After New Import Tariffs
Tariffs are moving again, and that can quickly change the risk and reward profile for U.S. manufacturers. With new charges…
Read More » -
OKYO Pharma Director John Brancaccio Purchases 5,000 Shares on Nasdaq
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company…
Read More »